Asia Pacific Medical Plastic Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Type (Standard Plastic, Engineering Plastic, High Performance Plastic (HPP), Silicone, and Others) and Application (Medical Disposables, Prosthetics, Medical Instruments and Tools, Drug Delivery, and Others)

ASIA PACIFIC MEDICAL PLASTIC RD

Asia Pacific Medical plastic Market Forecast to 2027 – COVID-19 Impact and Asia Pacific (APAC) Analysis – By Type (Standard plastic, Engineering plastic, High Performance Plastic (HPP), Silicone, and Others); Application (Medical Disposables, Prosthetics, Medical Instruments and Tools, Drug Delivery, and Others), and Country

Pages: 127   

Market Introduction

Medical plastics are made from a huge number of macromolecules, which are utilized to produce consistent and safe instruments in the healthcare industry. They are remarkably long-lasting, supple, and economical. The performance, sterility, and quality of these tools is a major factor for market expansion. Medical plastics find a broad range of applications in diagnostic instruments, implants, disposables, drug delivery devices, surgical instruments, syringes, and catheters. The global population is projected to increase in the coming years. With the increasing population, diseases and infections are rampantly overspreading through several mediums. The rising geriatric population further enhances the development of the healthcare sector. Moreover, medical plastics are also exploited in prosthetics, and it offers a life-changing solution for physically disabled people.

Market Overview and Dynamics

The Asia Pacific Medical plastic market was valued at US$ 4,745.4 million in 2019 and is projected to reach US$ 9,023.3 million by 2027; it is expected to grow at a CAGR of 8.4% during the forecast period. Factors driving the market growth advantages of using medical plastic and growing demand from packaged and processed food industry. However, the availability of substitutes is likely to have a negative impact on the market growth.

Key Market Segments

By type, the standard plastic segment accounted for the largest market share in the Asia Pacific medical plastic market in 2019. In terms of application, the medical application and tools segment held the largest market share of the medical plastic market by 2027.

Major Sources and Companies Listed

Some of the major primary and secondary sources for Asia Pacific Medical plastic market included in the report are Celanese Corporation, Eastman chemical company, GW Plastics, Orthoplastics Limited, Aran Biomedical, Rochling , SABIC , Saint-Gobain, Solvay , and Dow.

Impact of COVID-19 Pandemic on Medical plastic Market

The COVID-19 is anticipated to cause a loss of more than 3 Billion in the Asia Pacific region. The consequence and impact can be even worse and totally depends on the spread of the virus. The government of Asia Pacific is taking possible steps to reduce its effects by announcing lockdown, and thus, impact the revenue generated by the market. The Airports Council International (ACI) Asia-Pacific warned that the prolonged duration of the COVID-19 (COVID-19) outbreak would drastically impact the region’s airports’ connectivity and economic sustainability, significantly restricting them from achieving previously forecasted growth prospects. Such closures are anticipated to negatively impact market growth in the coming period. Until now, China has the highest number of COVID -19 confirmed cases.

Reasons to buy the report

• To understand the Medical plastic market landscape and identify market segments that are most likely to guarantee a strong return
• To stay ahead by comprehending the ever-changing competitive landscape for the Medical plastic market
• To efficiently plan M&A and partnership deals in the Medical plastic market by identifying market segments with most promising probable sales
• To take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments in the Medical plastic market
• To obtain market revenue forecast for market by various segments from 2018 to 2027

Asia Pacific Medical plastic Market Segmentation

By Type

• Standard Plastic
• Engineering Plastic
• High Performance Plastic (HPP)
• Silicone
• Others

By Application

• Medical Disposables
• Prosthetics
• Medical Instruments and Tools
• Drug Delivery
• Others

By Country

• China
• India
• Australia
• Japan
• South Korea
• Rest of Asia Pacific

Company Profiles

• Celanese Corporation
• Eastman chemical company
• GW Plastics
• Orthoplastics Limited
• Aran Biomedical
• Rochling
• SABIC
• Saint-Gobain
• Solvay
• Dow.  

Company Profiles

1. Celanese Corporation
2. Eastman chemical company
3. GW Plastics
4. Orthoplastics Limited
5. Aran Biomedical
6. Rochling
7. SABIC
8. Saint-Gobain
9. Solvay
10. Dow

• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific medical plastic market, thereby allowing players to develop effective long term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth the market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.